Introduction
Styryl ketones which have a,b-unsaturated ketone moiety are known as potential cytotoxic and anticancer compounds 1 . These compounds showed remarkable affinity for thiol groups and did not react with amino or hydroxy groups 2, 3 . Amino and hydroxy groups are available in nucleic acids, and hence a,b-unsaturated ketones may not have the genotoxic effects which are associated with various alkylating agents used in cancer chemotherapy 4 . Mannich bases are a group of compounds having various biological activities such as cytotoxic [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] anti-inflammatory 16, 17 and anticonvulsant 18, 19 activities. a,b-Unsaturated ketone/s available in the chemical structure of Mannich bases or produced from Mannich bases by deamination process is/are responsible for their cytotoxicities. a,b-Unsaturated ketones alkylate cellular thiols to produce cytotoxicity 20 . It was reported that Mannich bases of styryl ketones have increased cytotoxicity comparing to its styryl ketone analogue 21 . The cytotoxic and anticancer properties of chalcone (1,3-diphenyl-2-propenone) and related compounds have been reported 7, 8, 15, [22] [23] [24] [25] [26] [27] [28] . Conferring Mannich bases to phenolic chalcones increased their cytotoxicity 7, 8, 15, 26, 27 . Chalcones are conjugated molecules and sufficiently flexible to permit a wide variety of conformations. Hence, discernment of the optimal shape of molecule which is responsible for the cytotoxicity is not possible. The aim of the present study was to synthesize conformationally restricted chalcone analogue, 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one, and its Mannich bases (MT8-MT15). Different amines having different pK a values such as N-methyl piperazine (MT8), morpholine (MT9), piperidine (MT10), pyrrolidine (MT11), dimethylamine (MT12), diethylamine (MT13), dipropylamine (MT14) and dibenzylamine (MT15) were considered. Different pK a values can direct the deamination ratio and alkylation ratio of the compounds. It was also aimed to evaluate the cytotoxicities of the compounds against human tumour cell lines [gingival carcinoma (Ca9-22), oral squamous cell carcinoma (HSC-2, HSC-3 and HSC-4)] and human normal oral cells [gingival fibroblasts (HGF), periodontal ligament fibroblasts (HPLF) and pulp cells (HPC)].
Materials and methods
Melting points were determined using an Electrothermal 9100 (IA9100; Bibby Scientific Limited, Staffordshire, UK) instrument and are uncorrected.
1 H-NMR (400 MHz) and 13 C-NMR (100 MHz) spectra were obtained using a Varian Mercury Plus spectrometer (Varian Inc., Palo Alto, CA). Chemical shifts () were reported in parts per million. Mass spectra were undertaken on an HPLC-TOF Waters Micromass LCT Premier XE (Waters Corporation, Milford, MA) mass spectrometer using an electrospray ion source (ESI). All reactions were carried out in CEM Discover Microwave Synthesis Systems (CEM Corporation, Matthews, NC; 908010).
Synthesis of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one (MT1)
A solution of the 4-hydroxybenzaldehyde (0.02 mol) in ethanol (6 ml) was added into a stirred solution of 1-indanone (0.02 mol) in aqueous solution of sodium hydroxide (10 ml, 10%). Stirring was maintained at room temperature overnight. The reaction mixture was then poured onto water (100 ml) and neutralized with hydrochloric acid (10%, w/v). The precipitated solid product was filtered, washed with water, and crystallized from waterethanol 22, 29 (Scheme 1).
General synthesis of Mannich bases (MT8-MT15)
The mixture of the compound MT1 (21 mmol 
2-(4-Hydroxy
-3-(pyrrolidin-1-ylmethyl)benzylidene)-2,3- dihydroinden-1-one (MT11) Yield: 22.2%. m.p.: 152-154 C. 1 H-NMR (CDCl 3 ) 1.81-1.86 (4H, m, CH 2 -pyrrolidine), 2.62 (4H, s, CH 2 -pyrrolidine), 3.84 (2H, s, CH 2 -N), 3.90 (2H, s, indeno H-3), 6.84 (1H, d, phenyl H- 5, J ¼ 8.4 Hz), 7.24 (1H, s, phenyl H-2), 7.34 (1H, t, indeno H-6, J ¼ 6.6 Hz), 7.47-7.54 (4H, m, ¼CH-, indeno H-4, H-5, phenyl H-6), 7.83 (1H, d, indeno H-7, J ¼ 7.7
Biological activity

Cytotoxicity evaluation
The cytotoxicity of the compounds MT1 and MT8-MT15 was assayed towards human tumour cell lines [gingival carcinoma 
Results and discussion
In this study, 2- The cytotoxicities of these synthesized compounds were tested against Ca9-22, HSC-2, HSC-3 and HSC-4 human tumour cell lines and also against HGF, HPLF and HPC human normal oral cells. The cytotoxicity results were reported at Table 1 .
The first question to be answered is whether there is the antineoplastic property of the compounds or not. Except compound MT15, which is dibenzylamine derivative, CC 50 values (the concentration of the compound that kills 50% of the cells as mmol/L) were in 6.8 to41000 micromolar range towards Ca9-22, HSC-2, HSC-3 and HSC-4, which are cancer lines ( Table 1 ). The cytotoxic potencies of MT1 and its Mannich bases MT8-MT15 towards cell lines used were compared with clinically used anticancer drugs: melphalan (alkylating agent) and 5-fluorouracil (5-FU, pyrimidine antagonist). Only compound MT8 was more cytotoxic than melphalan and 5-FU towards HSC-2 and HSC-4 cell lines. The second aspect of these compounds to be considered is whether they are tumour-specific cytotoxins since tumours are surrounded by different types of normal cells in oral cavity. Selectivity index (SI) value, which is the quotient of the average CC 50 value of the non-malignant cells and the CC 50 value of a compound towards a specific malignant cell line, was generated. The compounds, which have SI values of41, can be considered as tumour-specific antineoplastic agents (Table 1) . Accordingly it can be said that the compounds MT8-MT14 have shown remarkable tumour specificity against all cancer cell lines except MT10 towards Ca9-22 and HSC-4 cell lines (Table 1) . However, MT10 showed the highest SI value against HSC-3 cells (SI ¼ 10.39).
When MT1 was converted to some Mannich bases, increased cytotoxicity was observed in MT8 (6. Additionally, increases in cytotoxicities of Mannich bases compared with MT1 were observed against HSC-4 cell lines. These compounds were MT8 (27.35 times), MT9 (1.04 times), MT11 (1.79 times), MT12 (2.29 times), MT13 (1.09 times) and MT14 (2.09 times). But when the increase in SI value was considered, compared with that of MT1 against HSC-4 cell lines, only MT8 (2.11 times) and MT14 (2.07 times) showed increased SI values. It is quite natural to observe different cytotoxicity levels for compounds which have different chemical structures towards different cell lines, since the mechanism of action for any compound can be different towards each cell line. That is why cytotoxicity value and selectivity index can be found different for any compound.
Lead compound/s should possess both marked cytotoxic potency and also selective toxicity for tumours. In order to identify such molecule/s, a potency selectivity expression (PSE) was devised which is the product of the reciprocal of average CC 50 values towards Ca9-22, HSC-2, HSC-3 and HSC-4 cells (that reflects cytotoxic potential, the column E, Table 1 ) and the average SI values towards these cell lines (that reflects the tumour-selectivity, the column J, Table 1 ) and expressed as a percentage. The PSE data are also shown in Table 1 . When PSE Table 1 . Cytotoxicities of the compounds and log P The only difference in chemical structure of Mannich bases synthesized was the difference of amine part. Amines used have different pK a values which may govern the cytotoxicity by affecting the deamination ratio. The compound MT8 has second nitrogen atom while the others has only one nitrogen atom. When six-membered cyclic amine compounds MT8 (N-methylpiperazine), MT9 (morpholine), MT10 (piperidine), MT11 (pyrrolidine) and acyclic amine compounds MT12 (dimethylamine), MT13 (diethylamine), MT14 (dipropylamine) and MT15 (dibenzylamine) were compared in terms of PSE value obtained, it was noticed that PSE values was in the order of MT84MT94MT10. It means that the contribution of different atom available in the cyclic amines into PSE value was in the order of N4O4C. PSE value of MT9 (0.0566) was $1/4 of MT8 (0.2262) while MT10 (5 0.0051) had 1/11 PSE value of MT9. When five-membered cyclic amine was used for MT11 instead of six-membered cyclic amine, the PSE value of MT11 (0.0517) was similar to that of MT9. On the other hand, when acyclic amines were used instead of cyclic amines such as dimethylamine, diethylamine and dipropylamines in MT12, MT13 and MT14, respectively, PSE values of MT12-MT14 (0.00145-0.1035) were quite lower than the compounds having six-membered cyclic amines.
When MT14, which has dipropylamine, was considered, its PSE value was more than five times of MT12 and MT13, and it was approximately two times higher than those of compounds MT9, which has six-membered cyclic amine morpholine, and MT11, which has five-membered cyclic amine pyrrolidine. It is quite natural to observe increased PSE values in MT14 compared with MT12 and MT13 because it has higher log P value than the other homologues MT12 with dimethylamine and MT13 with diethylamine (Table 1) . Increased log P value may increase membrane permeability of the compounds. On the other hand, although MT13 and MT10 had similar log P values as 3.74 and 3.79, respectively; PSE value of MT13 was approximately three times of MT10. This suggests that log P value may not be the sole determinant of PSE value of the compound. In addition, when PSE values of MT15 having dibenzylamine and MT12 having dimethylamine were compared, addition of two phenyl rings increased the log P values 1.5 times but caused the loss of activity and selectivity, supporting that cytotoxicity and PSE value of the compounds are not directly related to their log P value. The activity of the compounds may be related to their chemical structure, their stability, their mechanism of action and the cell type used.
Pyrrolidine and diethylamine are non-classical bioisoster with each other. MT11 having pyrrolidine ring had 3.6 times higher PSE value than that of MT13 having diethylamine. In this case, better selectivity was observed in conformationally restricted amine compound MT11.
In conclusion, the compound MT8 with the highest PSE value bearing N-methylpiperazine moiety seems to be a good candidate to develop new cytotoxic compounds and is suited for further investigation.
